Start of review of painkiller metamizole and risk of secondary cancers with CAR T-cell medicines
Board adopts Executive Director’s 2023 annual activity report and is updated on new fee regulation
EU collaboration to foster high-quality clinical research
How we contributed to public and animal health in the European Union
Q&A document clarifies regulatory requirements for devices used in combination with medicines
Have your say and help shape EMA’s future communications. The survey closes on 21 June 2024
Find medicine
What's new
FAQs
Latest news
Review will look into risk of agranulocytosis, a sudden drop in white blood cells that can lead to serious infections, and measures to minimise it.
Start of review of painkiller metamizole and risk of secondary cancers with CAR T-cell medicines.
Board adopts Executive Director’s annual activity report for 2023 and hears updates on implementation of new fee regulation.
Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.
EMA has issued recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2024.
EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its May 2024 meeting
Information for you
Patients and carers
Healthcare professionals
Animal health professionals
Pharmaceutical Industry
Media
